Pfizer's unexpected deal with the Trump administration on drug pricing sends shockwaves through the pharmaceutical industry, pressuring competitors to follow suit amidst potential regulatory threats. What’s next for drug prices?
In a surprising announcement, President Trump declared a 100% tariff on patented pharmaceuticals unless companies manufacture in the U.S., leaving many confused about the implications for drug prices and healthcare.
The U.S. is facing unprecedented health care cost increases, with employers likely to pass on hefty paycheck deductions and out-of-pocket expenses to workers. A new survey reveals a perfect storm brewing for American health care.
In a bold move, the Trump administration is sending out 100 cease-and-desist letters to drug companies, aiming to eliminate misleading ads. This crackdown includes increased transparency about drug risks and closing loopholes that conceal vital safety information.
In a surprising post on Truth Social, Trump raises doubts about the Covid vaccines developed during his presidency, demanding transparency from drug companies amid ongoing CDC turmoil.
In a bold move, President Trump calls for pharmaceutical companies to justify the success of their Covid drugs amid a leadership crisis at the CDC. As the FDA tightens vaccine eligibility, tensions rise over vaccine efficacy and public health transparency.
A new review claims antidepressants don’t cause significant withdrawal effects, but new research suggests otherwise. Long-term users may face severe and debilitating symptoms after stopping. Find out the shocking reality behind antidepressant withdrawal.
